BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10216125)

  • 1. Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
    Floreani A; Baragiotta A; Baldo V; Menegon T; Farinati F; Naccarato R
    Hepatology; 1999 May; 29(5):1425-8. PubMed ID: 10216125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).
    Floreani A; Biagini MR; Chiaramonte M; Milani S; Surrenti C; Naccarato R
    Ital J Gastroenterol; 1993; 25(9):473-6. PubMed ID: 8123893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
    Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
    Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
    Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis.
    Caballería L; Parés A; Castells A; Ginés A; Bru C; Rodés J
    Am J Gastroenterol; 2001 Apr; 96(4):1160-3. PubMed ID: 11316164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies in primary biliary cirrhosis.
    Piscaglia F; Sagrini E
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):1-4. PubMed ID: 18090981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers.
    Cavazza A; Caballería L; Floreani A; Farinati F; Bruguera M; Caroli D; Parés A
    Hepatology; 2009 Oct; 50(4):1162-8. PubMed ID: 19585656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Suzuki A; Lymp J; Donlinger J; Mendes F; Angulo P; Lindor K
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):259-64. PubMed ID: 17174610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis.
    Shibuya A; Tanaka K; Miyakawa H; Shibata M; Takatori M; Sekiyama K; Hashimoto N; Amaki S; Komatsu T; Morizane T
    Hepatology; 2002 May; 35(5):1172-8. PubMed ID: 11981767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden.
    Lööf L; Adami HO; Sparén P; Danielsson A; Eriksson LS; Hultcrantz R; Lindgren S; Olsson R; Prytz H; Ryden BO
    Hepatology; 1994 Jul; 20(1 Pt 1):101-4. PubMed ID: 8020878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S; Mason A; Eason J; Loss G; Perrillo RP
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cancer in primary biliary cirrhosis: the Mayo experience.
    Nijhawan PK; Therneau TM; Dickson ER; Boynton J; Lindor KD
    Hepatology; 1999 May; 29(5):1396-8. PubMed ID: 10216121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatocellular carcinoma in Italy: what could we learn from autoptic studies?
    Tiribelli C; Croce LS; Polo S; Sodde M; Stanta G
    Ital J Gastroenterol; 1991; 23(7):448-51. PubMed ID: 1660331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
    Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
    Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan.
    Harada K; Hirohara J; Ueno Y; Nakano T; Kakuda Y; Tsubouchi H; Ichida T; Nakanuma Y
    Hepatology; 2013 May; 57(5):1942-9. PubMed ID: 23197466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.